Cidara Therapeutics Executives Sell Shares Amidst Market Volatility

Cidara Therapeutics, Inc. (CDTX) announced that Director Bonnie L. Bassler sold 15 shares at $221.5/share on January 7, 2026. Similarly, Director Daniel D. Burgess sold 150 shares at $221.5/share on the same day. Chief Medical Officer Nicole Negar Davarpanah sold 12,553 shares at $221.5/share, while Chief Financial Officer Frank Karbe sold 7,526 shares at $221.5/share. Director Chrysa Mineo sold 3,320 shares at $221.5/share, and Director, President & CEO Jeffrey Stein sold 750 shares at $118.95/share on June 5, 2017. Stein also purchased 645 shares at $155/share on March 31, 2017, and sold 367 shares at $135.8/share on September 12, 2017. In addition, Stein purchased 2,500 shares at $40.01/share on November 10, 2020, and bought 367 shares at $135.8/share on September 12, 2017. Stein also sold 2,500 shares at $40.01/share on November 10, 2020. COO & CLO Shane Ward sold 25,083 shares at $221.5/share on January 7, 2026.